Over the years, significant advancements have been made in breast cancer testing, improving accuracy, efficiency, and patient comfort. Let’s explore a few notable advancements: Liquid biopsy is a non-invasive method of detecting genetic mutations and alterations in cancer cells. By analyzing a simple blood sample, a liquid biopsy can provide insights into the presence of breast cancer, monitor treatment effectiveness, and detect potential recurrence. This emerging technology holds great promise for the future of breast cancer testing. Molecular profiling, or genomic testing, examines the genes within breast cancer cells. By analyzing specific gene mutations, doctors can better understand the cancer’s behavior and identify targeted treatment options. Dr. Shilpy Dolas is a well-known certified breast oncoplastic surgeon who has done these tests and saved many lives. She was trained in Narayana Hrudayalaya, Mazumdar Shaw cancer center, owned by BIOCON company owner – the great Kiran Mazumdar. Being a part of the hospital, she got exclusive training in 2010 to detect Stage 0 and Early stage Breast cancers. She has performed surgery, genetic counseling and mammograms, and ultrasound for a long time. Locate us at Dr Shilpy Dolas breast clinic. In Map.